Treatment of mitochondrial diseases with an erythropoietin...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/18 (2006.01) A61P 25/00 (2006.01)

Patent

CA 2724841

Methods of treating mitochondrial disorders that are not respiratory chain disorders using compositions comprising EPO mimetic compounds or compounds capable of increasing endogenous EPO levels or stimulating erythropoiesis are disclosed. Methods of treating Friedreich's ataxia, Leigh's syndrome, or other disorders by increasing the expression of frataxin with an EPO mimetic compound or a compound capable of increasing endogenous EPO levels or stimulating erythropoiesis are also disclosed.

L'invention porte sur des procédés de traitement de troubles mitochondriaux qui ne sont pas des troubles de la chaîne respiratoire à l'aide de compositions comprenant des composés mimétiques d'EPO ou des composés capables d'augmenter les taux d'EPO endogène ou de stimuler l'érythropoïèse. L'invention porte également sur des procédés de  traitement de l'ataxie de Friedreich, du syndrome de Leigh ou autres troubles par l'augmentation de l'expression de la frataxine avec un composé mimétique d'EPO ou un composé capable d'augmenter les taux d'EPO endogène ou de stimuler l'érythropoïèse.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of mitochondrial diseases with an erythropoietin... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of mitochondrial diseases with an erythropoietin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of mitochondrial diseases with an erythropoietin... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1359640

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.